Propanc Biopharma Inc (PPCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,821 | -1,462 | -935 | -351 | -2,661 |
| Depreciation Amortization | 0 | 0 | 0 | 0 | 2 |
| Accounts payable and accrued liabilities | 242 | 243 | 169 | 149 | 81 |
| Other Working Capital | 417 | 522 | 185 | 97 | 473 |
| Other Operating Activity | 225 | 22 | 9 | -229 | 1,000 |
| Operating Cash Flow | $-935 | $-675 | $-572 | $-334 | $-1,105 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 982 | 823 | 767 | 493 | 590 |
| Debt Issued | 80 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 23 | 11 | N/A | N/A | 500 |
| Other Financing Activity | -143 | -143 | -143 | -143 | 24 |
| Financing Cash Flow | $942 | $691 | $624 | $350 | $1,114 |
| Exchange Rate Effect | 4 | -20 | 10 | -20 | -3 |
| Beginning Cash Position | 10 | 10 | 10 | 10 | 4 |
| End Cash Position | 21 | 6 | 72 | 7 | 10 |
| Net Cash Flow | $11 | $-4 | $62 | $-3 | $6 |
| Free Cash Flow | |||||
| Operating Cash Flow | -935 | -675 | -572 | -334 | -1,105 |
| Free Cash Flow | -935 | -675 | -572 | -334 | -1,105 |